Compare MasterCard Inc (MA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Medtronic PLC — how do they compare? MasterCard Inc trades at $589.14 (market cap $503.50B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: MasterCard Inc is far larger — about 4.5× Medtronic PLC's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and Medtronic PLC for 63 Days on average.
| MA | MDT | |
|---|---|---|
Market Cap | $503.50B | $112.24B |
Volume | 3,390,859 | 105,663,236 |
Sector | Financials | Health |
52-Week High | $599.86 | $105.35 |
52-Week Low | $471.55 | $73.75 |
Typical Hold Time | 134 Days | 63 Days |
Enterprise Value | $516.53B | $131.58B |
Dividend Yield | 0.61% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $574.76, up 0.82% with strong bullish technical signals. The company demonstrates robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining exceptional profit margins above 45%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $5.04 surpassing the $4.77 estimate. Analyst consensus remains overwhelmingly positive with 80% buy ratings and a $666.67 price target.
Mastercard presents a compelling growth opportunity with expanding digital payment adoption and strong financial performance. Key risks include payment industry disruption from stablecoins and AI-driven alternatives, though the company's aggressive innovation strategy positions it well. The stock trades at premium valuations (P/E 31.6) but justifies this with consistent earnings growth and market leadership.
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
